Showing results (41-50 of 60) with videos related to
Sort By:
Pageof 6
BMC Infectious Diseases|January 23, 2025
Unconventional use of injectable long-acting cabotegravir and rilpivirine against HIV-1 in PWH in clinical need: 52 weeks real-world dataValentina Iannone, Roberto Rossotti, Nicholas Brian Bana, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 31, 2023
Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohortAntonella d'Arminio Monforte, Alessandro Tavelli, Roberto Rossotti, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 19, 2025
Brief Report: New HIV Diagnoses in PrEP-Experienced and PrEP-Naive Persons in the ICONA CohortLucia Taramasso, Roberto Rossotti, Alessandro Tavelli, et al.Sexual Health|July 1, 2026
Non-occupational post-exposure prophylaxis does not expand or differentiate candidates for pre-exposure prophylaxisNicholas Brian Bana, Leonardo Francesco Rezzonico, Gabriele Cavazza, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 2, 2024
Oral HPV infection clearance and acquisition after nonavalent vaccination in men who have sex with men and transgender women: a prospective analysisRoberto Rossotti, Alice Nava, Chiara Baiguera, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2026
A randomized clinical trial to compare moxiFloxAcin veRsus aziTHromycin for the trEatment of MycoplaSma geniTalium: the FARTHEST StudyRoberto Rossotti, Chiara Baiguera, Davide Paolo Bernasconi, et al.Microorganisms|April 26, 2025
Outbreak of Vancomycin-Resistant Enterococcus in a NICU: Insights into Molecular Detection and Infection ControlFrancesco Peracchi, Giovanna Travi, Alice Proto, et al.Sexually Transmitted Infections|April 19, 2024
Performance evaluation of a self-administered point-of-care test for anal HPV screening in PrEP users: data from a community-based PrEP serviceLorenzo Biasioli, Roberto Rossotti, Alessandro Tavelli, et al.The Journal of Infection|July 12, 2020
Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysisRoberto Rossotti, Giovanna Travi, Nicola Ughi, et al.Ebiomedicine|August 23, 2024
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona)Valentina Mazzotta, Silvia Nozza, Simone Lanini, et al.Pageof 6